Your browser doesn't support javascript.
loading
The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review.
Koch, Birgit C P; Zhao, Qiaolin; Oosterhoff, Maartje; van Oldenrijk, Jakob; Abdulla, Alan; de Winter, Brenda C M; Bos, Koen; Muller, Anouk E.
Afiliação
  • Koch BCP; Department of Hospital Pharmacy, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Zhao Q; CATOR, Center for Antimicrobial Optimized Treatment Rotterdam, Rotterdam, The Netherlands.
  • Oosterhoff M; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.
  • van Oldenrijk J; Department of Hospital Pharmacy, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Abdulla A; Rotterdam Clinical Pharmacometrics Group, Rotterdam, The Netherlands.
  • de Winter BCM; Department of Hospital Pharmacy, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Bos K; Department of Orthopaedics and Sports Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • Muller AE; Department of Hospital Pharmacy, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Expert Opin Drug Metab Toxicol ; 18(9): 587-600, 2022 Sep.
Article em En | MEDLINE | ID: mdl-36008360
ABSTRACT

INTRODUCTION:

Currently, antibiotic treatment is often a standard dosing regimen in bone and joint infections (BJI). However, it remains unknown if exposure at the target-site is adequate. The aim of this review is to gain more insight in the relationship between the target site concentration of antibiotic and the minimal inhibitory concentration to target the bacteria in bone and joint infections (BJI). AREAS COVERED A literature search was performed by Erasmus MC Medical library. Bone, bone tissue and synovial concentration of antibiotics were covered in humans. In addition, we reported number of patients, dose, sampling method, analytical method and tissue and plasma concentrations. We used the epidemiological cutoff value (ECOFF) values of the targeted micro-organisms. If more than 3 publications were available on the antibiotic, we graphically presented ECOFFS values against reported antibiotic concentrations. EXPERT OPINION For most antibiotics, the literature is sparse. In addition, a lot of variable and total antibiotic concentrations are published. Ciprofloxacin, cefazolin, cefuroxime, vancomycin and linezolid seem to have adequate average exposure if correlating total concentration to ECOFF, when standard dosing is used. With regard to other antibiotics, results are inconclusive. More extensive pharmacokinetic/pharmacodynamic modeling in BJI is needed.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefazolina / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cefazolina / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article